Federal Register of Legislation - Australian Government

Primary content

PB 48 of 2010 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) and determines conditions for payments in respect of supply of pharmaceutical benefits by approved pharmacists and medical practitioners.
Administered by: Health
Registered 21 May 2010
Tabling HistoryDate
Tabled HR26-May-2010
Tabled Senate15-Jun-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 48 of 2010

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, FELICITY McNEILL, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

 

Dated                                                                           12 May 2010

 

 

 

 

 

FELICITY McNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing


Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 June 2010.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.



Schedule 1            Amendments

 

[1]      Schedule 4, after item dealing with Aciclovir

insert in the columns in the order indicated:

 

Alendronic acid with colecalciferol and calcium

Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate)

[2]      Schedule 4, item dealing with Cromoglycic Acid

omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses

[3]      Schedule 4, item dealing with Glucose Indicator—Blood

(a) insert as first entry in the column headed “Form (strength, type, size, etc.)”:

 

 

Test strips, 100 (Accu-Chek Mobile)

(b) omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Test strips, 100 (Precision Plus)

[4]      Schedule 4, omit item dealing with Mineral mixture

[5]      Schedule 4, item dealing with Rivaroxaban

omit from the column headed “Form (strength, type, size, etc.)”:

 

 

Tablets 10 mg, 15